CLINICAL_TRIALS
trial_result
· 2025-09-10
Clinical Trial Update: Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes Mellitus [Phase 2]
Summary
A Phase 2 trial evaluating Biomea Fusion's BMF-219 in Type 1 Diabetes Mellitus was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biomea Fusion Inc. | Conditions: Type 1 Diabetes Mellitus | Phase 2 | Status: TERMINATED